Pelletier, Champagne, Stifani, Yang: "MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2." dans: Oncogene, Vol. 21, Issue 17, pp. 2729-40, 2002 (PubMed).
Kitabayashi, Aikawa, Nguyen, Yokoyama, Ohki: "Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein." dans: The EMBO journal, Vol. 20, Issue 24, pp. 7184-96, 2001 (PubMed).
Mao, Frank, Zhang, Miyazaki, Nimer: "Functional and physical interactions between AML1 proteins and an ETS protein, MEF: implications for the pathogenesis of t(8;21)-positive leukemias." dans: Molecular and cellular biology, Vol. 19, Issue 5, pp. 3635-44, 1999 (PubMed).
Levanon, Goldstein, Bernstein, Tang, Goldenberg, Stifani, Paroush, Groner: "Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 95, Issue 20, pp. 11590-5, 1998 (PubMed).
Bruhn, Munnerlyn, Grosschedl: "ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function." dans: Genes & development, Vol. 11, Issue 5, pp. 640-53, 1997 (PubMed).
Ghozi, Bernstein, Negreanu, Levanon, Groner: "Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 93, Issue 5, pp. 1935-40, 1996 (PubMed).
Nucifora, Birn, Espinosa, Erickson, LeBeau, Roulston, McKeithan, Drabkin, Rowley: "Involvement of the AML1 gene in the t(3,21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis." dans: Blood, Vol. 81, Issue 10, pp. 2728-34, 1993 (PubMed).